$Clover Health (CLOV.US)$ shares experienced a rise of 19.99% in post-market trading on Tuesday following the announcement of a multi-year agreement by one of its subsidiaries with The Iowa Clinic.
Details of the Agreement: A subsidiary of Clover Health, Counterpart Health, has entered into a multi-year contract with the multispecialty healthcare group, The Iowa Clinic. This partnership involves providing Counterpart Health's cloud-based software platform to clinicians who manage care for the clinic’s Medicare Advantage and Medicare Shared Savings Program patients.
Platform Features and Benefits: Counterpart Assistant software will also be accessible to partners in The Iowa Clinic’s integrated network across the Midwest. Clover Health's subsidiary will receive a per-member, per-month payment and may also receive additional incentive payments based on the achievement of specific care management objectives.
Executive Commentary: “Counterpart Assistant was developed in one of the nation’s toughest healthcare markets, drawing interest from top payers and provider groups focused on meeting the intricate needs of patients in challenging environments,” stated Andrew Toy, CEO of Clover Health.“The Iowa Clinic is a leader in pioneering value-based care solutions. We believe our technology will provide significant clinical value to the numerous esteemed physicians in this group and their Medicare patients,” Toy added.
オーストラリアでは、moomooの投資商品及びサービスはMoomoo Securities Australia Limitedによって提供され、オーストラリア証券投資委員会(ASIC)の管理を受けております(AFSL No. 224663)。「金融サービスガイド」、「利用規約」、「プライバシーポリシー」などの詳細は、Moomoo Securities Australia Limitedのウェブサイトhttps://www.moomoo.com/auでご確認いただけます。
オーストラリアでは、moomooの投資商品及びサービスはMoomoo Securities Australia Limitedによって提供され、オーストラリア証券投資委員会(ASIC)の管理を受けております(AFSL No. 224663)。「金融サービスガイド」、「利用規約」、「プライバシーポリシー」などの詳細は、Moomoo Securities Australia Limitedのウェブサイトhttps://www.moomoo.com/auでご確認いただけます。